Germline mutation in the TP53 gene in uveal melanoma

被引:15
作者
Hajkova, Nikola [1 ,2 ]
Hojny, Jan [1 ,2 ]
Nemejcova, Kristyna [1 ,2 ]
Dundr, Pavel [1 ,2 ]
Ulrych, Jan [2 ,3 ]
Jirsova, Katerina [2 ,4 ]
Glezgova, Johana [2 ,5 ]
Ticha, Ivana [1 ,2 ]
机构
[1] Charles Univ Prague, Fac Med 1, Inst Pathol, Prague, Czech Republic
[2] Gen Univ Hosp Prague, Prague, Czech Republic
[3] Charles Univ Prague, Fac Med 1, Dept Abdominal Thorac Surg & Traumatol, Dept Surg 1, Prague, Czech Republic
[4] Charles Univ Prague, Fac Med 1, Clin Pediat & Adolescent Med, Prague, Czech Republic
[5] Charles Univ Prague, Fac Med 1, Dept Ophthalmol, Prague, Czech Republic
来源
SCIENTIFIC REPORTS | 2018年 / 8卷
关键词
LI-FRAUMENI-SYNDROME; P53; GENE; BREAST-CANCER; EXPRESSION; TUMOR; BAP1; ATM; SPECTRUM; THERAPY; PROFILE;
D O I
10.1038/s41598-018-26040-0
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
We performed comprehensive molecular analysis of five cases of metastasizing uveal malignant melanoma (UM) (fresh-frozen samples) with an NGS panel of 73 genes. A likely pathogenic germline TP53 mutation c. 760A > G (p. I254V) was found in two tumor samples and matched nontumor tissue. In three cases, pathogenic BAP1 mutation was detected together with germline missense variants of uncertain significance in ATM. All cases carried recurrent activating GNAQ or GNA11 mutation. Moreover, we analyzed samples from another 16 patients with primary UM by direct Sanger sequencing focusing only on TP53 coding region. No other germline TP53 mutation was detected in these samples. Germline TP53 mutation, usually associated with Li-Fraumeni syndrome, is a rare event in UM. To the best of our knowledge, only one family with germline TP53 mutation has previously been described. In our study, we detected TP53 mutation in two patients without known family relationship. The identification of germline aberrations in TP53 or BAP1 is important to identify patients with Li-Fraumeni syndrome or BAP1 cancer syndrome, which is also crucial for proper genetic counseling.
引用
收藏
页数:7
相关论文
共 54 条
[11]  
Foretova L, 2010, Klin Onkol, V23, P388
[12]   Primary node negative breast cancer in BRCA1 mutation carriers has a poor outcome [J].
Foulkes, WD ;
Chappuis, PO ;
Wong, N ;
Brunet, JS ;
Vesprini, D ;
Rozen, F ;
Yuan, ZQ ;
Pollak, MN ;
Kuperstein, G ;
Narod, SA ;
Bégin, LR .
ANNALS OF ONCOLOGY, 2000, 11 (03) :307-313
[13]   Evolving systemic targeted therapy strategies in uveal melanoma and implications for ophthalmic management: a review [J].
Goh, Amanda Y. L. ;
Layton, Christopher J. .
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2016, 44 (06) :509-519
[14]   High frequency of de novo mutations in Li-Fraumeni syndrome [J].
Gonzalez, K. D. ;
Buzin, C. H. ;
Noltner, K. A. ;
Gu, D. ;
Li, W. ;
Malkin, D. ;
Sommer, S. S. .
JOURNAL OF MEDICAL GENETICS, 2009, 46 (10) :689-693
[15]   TP53 Mutation Spectrum in Smokers and Never Smoking Lung Cancer Patients [J].
Halvorsen, Ann R. ;
Silwal-Pandit, Laxmi ;
Meza-Zepeda, Leonardo A. ;
Vodak, Daniel ;
Phuong Vu ;
Sagerup, Camilla ;
Hovig, Eivind ;
Myklebost, Ola ;
Borresen-Dale, Anne-Lise ;
Brustugun, Odd T. ;
Helland, Aslaug .
FRONTIERS IN GENETICS, 2016, 7
[16]   The genetics of uveal melanoma: an emerging framework for targeted therapy [J].
Harbour, J. William .
PIGMENT CELL & MELANOMA RESEARCH, 2012, 25 (02) :171-181
[17]   Frequent Mutation of BAP1 in Metastasizing Uveal Melanomas [J].
Harbour, J. William ;
Onken, Michael D. ;
Roberson, Elisha D. O. ;
Duan, Shenghui ;
Cao, Li ;
Worley, Lori A. ;
Council, M. Laurin ;
Matatall, Katie A. ;
Helms, Cynthia ;
Bowcock, Anne M. .
SCIENCE, 2010, 330 (6009) :1410-1413
[18]   A Landscape of Driver Mutations in Melanoma [J].
Hodis, Eran ;
Watson, Ian R. ;
Kryukov, Gregory V. ;
Arold, Stefan T. ;
Imielinski, Marcin ;
Theurillat, Jean-Philippe ;
Nickerson, Elizabeth ;
Auclair, Daniel ;
Li, Liren ;
Place, Chelsea ;
DiCara, Daniel ;
Ramos, Alex H. ;
Lawrence, Michael S. ;
Cibulskis, Kristian ;
Sivachenko, Andrey ;
Voet, Douglas ;
Saksena, Gordon ;
Stransky, Nicolas ;
Onofrio, Robert C. ;
Winckler, Wendy ;
Ardlie, Kristin ;
Wagle, Nikhil ;
Wargo, Jennifer ;
Chong, Kelly ;
Morton, Donald L. ;
Stemke-Hale, Katherine ;
Chen, Guo ;
Noble, Michael ;
Meyerson, Matthew ;
Ladbury, John E. ;
Davies, Michael A. ;
Gershenwald, Jeffrey E. ;
Wagner, Stephan N. ;
Hoon, Dave S. B. ;
Schadendorf, Dirk ;
Lander, Eric S. ;
Gabriel, Stacey B. ;
Getz, Gad ;
Garraway, Levi A. ;
Chin, Lynda .
CELL, 2012, 150 (02) :251-263
[19]   Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma [J].
Hugo, Willy ;
Zaretsky, Jesse M. ;
Sun, Lu ;
Song, Chunying ;
Moreno, Blanca Homet ;
Hu-Lieskovan, Siwen ;
Berent-Maoz, Beata ;
Pang, Jia ;
Chmielowski, Bartosz ;
Cherry, Grace ;
Seja, Elizabeth ;
Lomeli, Shirley ;
Kong, Xiangju ;
Kelley, Mark C. ;
Sosman, Jeffrey A. ;
Johnson, Douglas B. ;
Ribas, Antoni ;
Lo, Roger S. .
CELL, 2016, 165 (01) :35-44
[20]  
Ibrahim SO, 1999, INT J CANCER, V81, P527, DOI 10.1002/(SICI)1097-0215(19990517)81:4<527::AID-IJC4>3.0.CO